1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from:, accessed in June 2022;
  2. Arnold M, Karim-Kos HE, Coebergh JW, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur J Cancer 2015; 51(9):1164- 87;
  3. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46:765–781;
  4. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013; 49, 1374–1403;
  5. Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer 2003; 97:1894–903;
  6. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 13:739–44;
  7. Mottet N, Cornford P, van den Bergh R.C.N, et al. EAU EANM – ESTRO – ESUR – ISUP – SIOG Guidelines on Prostate Cancer 2022. Available from:;
  8. Sinescu I, Chibelean C, Cerempei V, et al. Cancerul de prostată. In Sinescu I, Gluck G. Tratat de Urologie, Editia I, Volum III, Editura Medicală, București. 2008; 2355-7.